CLINICAL_TRIALS
trial_result
· 2018-02-12
Clinical Trial Update: Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease [Phase 2]
Summary
Phase 2 study comparing SB-742457 or donepezil against placebo in mild-to-moderate Alzheimer's disease; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-02-12